• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

IL23A CLOSTRIDIUM DIFFICILE PARKINSON DISEASE ESCHERICHIA COLI DIABETES MELLITUS CELL DIFFERENTIATION TNF CELL PROLIFERATION RECEPTOR AUTOPHAGY IMMUNE RESPONSE TH17 CELLS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CELL DEATH PORPHYROMONAS GINGIVALIS CANCER PSEUDOMONAS AERUGINOSA APOPTOTIC PROCESS DOXORUBICIN ALZHEIMER'S DISEASE IFNG SOD1 LISTERIA MONOCYTOGENES METFORMIN TP53 BREAST CANCER AGING CTLA4 INSULIN ANGIOGENESIS INFLAMMATION ERBB-2 REMICADE CASP3 IL6 STAPHYLOCOCCUS AUREUS STREPTOCOCCUS PNEUMONIAE RHEUMATOID ARTHRITIS CD4 CANDIDA ALBICANS NEURODEGENERATIVE DISORDERS IL17A CELL DIVISION HELICOBACTER PYLORI FOXP3

© 2019 Biovista Vizit All Rights Reserved.